How Replacements of the 12 Conserved Histidines of Subunit I Affect Assembly, Cofactor Binding, and Enzymatic Activity of the Bradyrhizobium japonicum cbb3-type Oxidase*

Rachel Zufferey, Engin Arslan, Linda Thöny-Meyer, and Hauke HenneckeDagger

From the Mikrobiologisches Institut, Eidgenössische Technische Hochschule, Schmelzbergstrasse 7, CH-8092 Zürich, Switzerland

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Alignments of the amino acid sequences of subunit I (FixN or CcoN) of the cbb3-type oxidases show 12 conserved histidines. Six of them are diagnostic of heme-copper oxidases and are thought to bind the following cofactors: the low spin heme B and the binuclear high spin heme B-CuB center. The other six are FixN(CcoN)-specific and their function is unknown. To analyze the contribution of these 12 invariant histidines of FixN in cofactor binding and function of the Bradyrhizobium japonicum cbb3-type oxidase, they were substituted by valine or alanine by site-directed mutagenesis. The H131A mutant enzyme had already been reported previously to be defective in oxidase assembly and function (Zufferey, R., Thöny-Meyer, L., and Hennecke, H. (1996) FEBS Lett. 394, 349-352). Four of the remaining histidines were not essential for activity or assembly (positions 226, 246, 333, and 457); by contrast, histidines 331, 410, and 418 were required both for activity and stability of the enzyme. The last group of mutant enzymes, H420A, H280A, H330A, and H316V, were assembled but not functional. To purify the latter mutant proteins and the wild-type enzyme, a six-histidine tag was added to the C terminus of subunit I. The His6-tagged cbb3-oxidase complexes were purified 20-fold by a three-step purification protocol. With the exception of the H420A mutant oxidase, the mutant enzymes H280A, H316V, and H331A contained normal amounts of copper and heme B, and they displayed similar visible light spectroscopic characteristics like the wild-type His6-tagged enzyme. The His6-tagged H420A mutant oxidase differed from the His6-tagged wild-type protein by showing altered visible light spectroscopic characteristics. No stable mutant oxidase lacking copper or heme B was obtained. This strongly suggests that copper and heme B incorporations in subunit I are prerequisites for assembly of the enzyme.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Terminal cytochrome c oxidases are multimeric membrane protein complexes that catalyze the 2-electron oxidation of cytochrome c and the 4-electron reduction of oxygen to water. This process is usually coupled with the extrusion of protons toward the periplasm. Cytochrome c oxidases belong to the so-called superfamily of heme-copper oxidases (for a review, see Ref. 2). They have in common a low spin heme moiety and a so-called binuclear center composed of a high spin heme and CuB, where the oxygen reduction chemistry occurs. These cofactors are associated with subunit I and are bound by six strictly conserved histidines (3-5). Other typical features of cytochrome c oxidases are the presence of (i) a binuclear CuA center in subunit II, which is the entry site for electrons derived from reduced cytochrome c, and (ii) a Mn2+ or Mg2+ redox-inactive center that lies between subunits I and II (6, 7). The cbb3-type oxidase was found a few years ago to be a novel type of a cytochrome c oxidase with regard to subunit composition and content of prosthetic groups. It was first discovered in Bradyrhizobium japonicum and other rhizobial species and found to be essential for nitrogen fixation in symbiosis with the host plant (8-11). For this reason, the operon encoding the cbb3-type oxidase subunits was named fixNOQP. In the meantime, similar operons were also found in non-symbiotic bacteria, for which the ccoNOQP nomenclature (mnemonic for cytochrome c oxidase) was the preferred designation (12, 13). The B. japonicum cbb3-type oxidase is expressed under a low oxygen concentration (free-living and symbiotic) (14). This is in accordance with the high affinity for oxygen of the B. japonicum enzyme (KM = 7 nM; see Ref. 14).

Subunit I (FixN in B. japonicum), the largest subunit of the cbb3-type oxidase, is a 12-transmembrane-helix protein with a molecular mass of 61 kDa and contains two hemes of the B type and a CuB (1, 14, 15). The high spin heme B forms a binuclear center with the CuB metal (15, 16). The cbb3-type oxidase lacks a CuA-containing subunit II. Instead, two subunits (FixO and FixP) are c-type cytochromes that are anchored in the cytoplasmic membrane by their N-terminal transmembrane helix. FixO corresponds to subunit II, as inferred from the redox potential of the homologous Rhodobacter capsulatus protein (16) and its role in assembly (17, 18). It is a monoheme cytochrome c of 28 kDa. FixP is a diheme cytochrome c of 32 kDa (18). The fixQ gene product has a molecular mass of 6 kDa and is thought to be inserted in the membrane by its hydrophobic N terminus. This small subunit is neither essential for the function nor for assembly of the enzyme (17). It is still unknown whether or not this gene product is part of the cbb3-type oxidase complex. The purified enzyme of B. japonicum as well as that of three non-symbiotic bacteria were identified as three-subunit complexes, and the presence of FixQ in such preparations has never been reported (15-17, 19).

Subunit I of the cbb3-type oxidase differs from the classical subunit I of terminal oxidases of the heme-copper oxidase family by two notable criteria: (i) it has a lower degree of similarity on the amino acid sequence level (20%, see Ref. 8), and (ii) it possesses in addition to the six canonical histidines conserved in all subunits I of heme-copper oxidases a further six histidines conserved in all FixN homologues (Fig. 1). The canonical histidines His-131, His-280, His-330, His-331, His-418, and His-420 of the B. japonicum FixN protein correspond to the histidines His-94, His-276, His-325, His-326, His-411, and His-413 of the Paracoccus denitrificans aa3-type cytochrome c oxidase subunit I, which ligate the hemes and CuB cofactors, as shown unequivocally by the crystal structure of the bacterial and mitochondrial aa3-type cytochrome oxidases (3-5). All of them are located on the periplasmic face of the membrane. His-276, His-325, and His-326 (using the numbering of P. denitrificans cytochrome aa3) are involved in complexing CuB. His-411 serves as the high spin heme ligand. The two other histidines, His-94 and His-413, bind the low spin heme. One of the CuB ligands (His-325) was proposed to be implicated in both reduction of oxygen and proton pumping (3). The six non-canonical histidines conserved specifically in FixN homologues are also predicted to be located on the borders of the membrane (Fig. 1; Ref. 8). His-246, His-333, and His-410 (using the B. japonicum numbering) are proposed to be on the periplasmic side and His-227, His-316, and His-457 on the cytoplasmic side of the membrane (Fig. 1). His-410 corresponds to the histidine that ligates a Mg2+ or Mn2+ metal center in many cytochrome c oxidases but not in quinol oxidases (6, 7). It is predicted to be localized on a periplasmic loop (20-22).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Topological model of subunit I (FixN) of B. japonicum cbb3-type oxidase. The black circles represent the invariant histidines present in subunit I of all heme-copper oxidases, whereas the gray circles symbolize the histidines conserved only in the FixN-homologous proteins. The histidines are numbered according to the amino acid sequence. The rectangles depict the hydrophobic segments. C, C terminus; N, N terminus; i, cytoplasm (inside); o, periplasm (outside).

In the present work, all of the conserved histidines of B. japonicum FixN were point-mutated to a neutral, smaller amino acid. These mutant variants were analyzed with respect to assembly in the membrane, cytochrome c oxidase activity, and nitrogen fixation in symbiosis with soybean. Among these mutations, only four, H316V (conserved FixN-specific residue), H420A (putative low spin heme B ligand), H280A, and H330A (putative CuB ligands) were found to cause inactive enzymes that were assembled in the membrane. Hexahistidine-tagged derivatives of these enzymes and of the wild-type enzyme were purified to homogeneity in a three-step purification procedure, including anion-exchange and Ni2+ affinity chromatographies and a gel filtration. We determined the copper and heme B contents and performed difference visible light spectroscopy with the purified mutant proteins.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Bacterial Strains and Growth Conditions-- All B. japonicum strains used in this work are listed in Table I. B. japonicum strains were grown at 28 °C either aerobically or anaerobically in PSY medium (8, 23) or in YEM medium supplemented with 10 mM KNO3, respectively (24). Antibiotics were added at the following concentrations (µg/ml): spectinomycin (100); tetracycline (60); chloramphenicol (10). Escherichia coli was grown in LB medium (25) to which antibiotics were added at the following concentrations (µg/ml): ampicillin (150); kanamycin (50); tetracycline (10). E. coli DH5alpha (26) was used for amplification of double strand plasmids and JM101 (27) for amplification of coliphage M13. B. japonicum was conjugated with the help of the E. coli donor strain S17-1 (28).

                              
View this table:
[in this window]
[in a new window]
 
Table I
B. japonicum strains and mutagenic primers

Recombinant DNA Work and Construction of the Mutants-- Standard procedures were used for cloning, Southern blotting, and hybridization (25). Chromosomal DNA of B. japonicum was isolated according to Hahn and Hennecke (29). DNA hybridization probes were radioactively labeled using the nick-translation technique (25). DNA sequence analyses were performed using the chain termination method (30) and the equipment for automated DNA sequencing (Sequencer model 370A and fluorescent dye terminators from Applied Biosystems, Foster City, CA).

All mutagenic primers used in this work are listed in Table I. The following mutations in FixN, H227A, H246V, H330A, and H333V (pRJ4619, pRJ4616, pRJ4564, and pRJ4612, respectively, all pSUP202pol6K derivatives (17), see below), were created by a one-step polymerase chain reaction (PCR)1 using pRJ4520 as a template (1.1-kb SacII-SphI fragment of fixN in M13BM21). The PCR-amplified DNA fragment containing the H227A mutation was cloned as a 0.6-kb SacII-XmnI fragment, and the H246V mutation was created as a 0.42-kb PvuI-SphI fragment of fixN to replace the corresponding wild-type gene region. The 0.24-kb AvaII-SphI PCR-amplified fragments containing the H330A or the H333V mutations were ligated into the same sites of fixN. All other mutations in fixN were obtained by a two-step PCR as described by Landt et al. (31). H280A, H316V, H331A, H410A, and H457A mutations (pRJ4565, pRJ4558, pRJ4563, pRJ4534, and pRJ4573, respectively, all pSUP202pol6K derivatives, see below) were introduced in a 1.1-kb SacII-SphI fragment, whereas H410A and H457A were brought in a 0.36-kb SphI-NsiI fragment. In the case of H418V (pRJ4533, pSUP202pol6K derivative, see below), the phosphorothiolate-based site-directed mutagenesis for single strand vectors (32) was applied with pRJ4521 (0.36-kb SphI-NsiI fragment of fixN in M13BM21) as a template. The corresponding point-mutated DNA fragment was cloned as a 0.36-kb SphI-NsiI fragment.

The insertion of six histidine codons (CAC) before the stop codon at the 3' terminus of fixN was achieved by a two-step PCR as described by Landt et al. (31) with pRJ4504 and pRJ4569 (17) used as templates for the first and second step of PCR mutagenesis. The amplified (CAC)6 insertion-containing fragment was cloned as a 0.6-kb NsiI-EcoRV fragment (3'-part of fixN', 5'-part of fixO') replacing the corresponding wild-type DNA region. The pSUP202pol6K (17) derivative containing 'orf277, orf141, and fixNOQP with the (CAC)6 insertion at the 5'-end of fixN is called pRJ4621. The (CAC)6 insertion was also introduced at the end of the genes with the histidine mutations H280A, H330A, H316V, and H420A by exchanging the wild-type 2.0-kb NsiI-XbaI fragment of pRJ4565, pRJ4564, pRJ4558, and pRJ4572 (see below) with the corresponding fragment containing the (CAC)6 insertion just before the stop codon of fixN, leading to pRJ4623, pRJ4622, pRJ4624, and pRJ4625, respectively.

All mutations were verified by sequencing. The plasmids pRJ4533, pRJ4534, pRJ4558, pRJ4563, pRJ4564, pRJ4565, pRJ4572, pRJ4573, pRJ4612, pRJ4616, pRJ4619, pRJ4621, pRJ4622, pRJ4623, pRJ4624, and pRJ4625 carried the 4.7-kb fragment carrying 'orf277, orf141, and the fixNOQP operon in the integration plasmid pSUP202pol6K similarly as pRJ4504 (17), and they contained the respective fixN mutations described above; they were cointegrated into the chromosome of B. japonicum Bj4503 (Delta fixNOQP; Ref. 14) as described by Zufferey et al. (17) leading to strains H418V, H410A, H316V, H331A, H330A, H280A, H420A, H457A, H333V, H246V, H227A, Bj4621, Bj4622, Bj4623, Bj4624, and Bj4625, respectively. The correct cointegrates were verified by Southern blot hybridization.

Purification of the His6-tagged cbb3-Oxidase from Strain Bj4621-- Membrane fractions of anaerobically grown 10-liter batch cultures were isolated as described previously (17) with the following modifications: the membranes were solubilized (45 min, 4 °C) in 20 mM Tris-HCl (pH 8.0), 1 mM phenylmethanesulfonyl fluoride, 100 mM NaCl, and 0.5% dodecyl maltoside (Sigma) at a protein concentration of approximately 3 mg/ml. The ultracentrifugation step was then repeated. The solubilized membrane fraction (supernatant) was loaded on a Q-Sepharose Fast Flow column (Pharmacia Biotech Inc., Sweden) that had been equilibrated with buffer A (20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 0.01% dodecyl maltoside). All the purification steps were done at room temperature at a free flow of 1 ml/min. The column was washed with 3 volumes of buffer A. Then the cbb3-oxidase was eluted with 3 volumes of buffer A in which the NaCl concentration was 250 mM. To this fraction was added 5 mM imidazole before loading it on a Ni2+ affinity column (His Bond Resin, Novagen) that had been prepared as described by the manufacturer and equilibrated with buffer B (20 mM Tris-HCl (pH 8.0), 20 mM NaCl, 0.01% dodecyl maltoside, and 5 mM imidazole). After loading, the column was washed with 3 bed volumes of buffer B. Then, the contaminants were removed with 3 bed volumes of buffer B containing 20 mM imidazole, and finally the cytochrome c oxidase was eluted with 250 mM imidazole in buffer B. The fractions containing the cbb3-type oxidase were desalted and buffer-exchanged by passing them through a prepacked Sephadex G-25 gel filtration column (PD-10 of Pharmacia, Sweden) following the instructions of the manufacturer, using 20 mM Tris-HCl (pH 7.5) buffer containing 0.01% dodecyl maltoside. The purified enzyme was concentrated to 2-5 mg/ml by ultrafiltration. The cbb3-oxidase was deprived of metal contaminants by incubating it with 5% (w/v) Chelex 100 (Bio-Rad) for 30 min at 4 °C. This treatment did not alter the activity of the enzyme. After a short centrifugation the supernatant containing the enzyme was stored at 4 °C without any loss of activity for at least 1 month.

Enzymatic and Biochemical Assays-- Tetramethyl-p-phenylenediamine (TMPD) oxidase activity, cytochrome c oxidase activity with reduced horse heart cytochrome c as the electron donor, and symbiotic nitrogen fixation activity were measured as described before (17). Protein concentration was determined by the bicinchoninic acid assay (Pierce) with bovine serum albumin as the standard. SDS-PAGE according to Laemmli (33) or Schägger and von Jagow (34) and heme stains were performed as described previously (17). Western blot analyses with antibodies against FixN, FixO, FixP, and CycM were performed as described previously (17, 35). Antiserum directed against a FixQ peptide (C terminus of FixQ from position 38 to 54: RNKAAFDEAAHLPLREE) was purchased from TANA Laboratories LC (Houston, TX). For immunodetection of FixQ, protein was loaded on a 12% Schägger and von Jagow gel and electroblotted (40 min for 1-mm thick gel) onto a polyvinylidene difluoride membrane (Millipore Corporation, Bedford, MA) that was underlaid by a nitrocellulose membrane (Hybond-C, Amersham, UK). Detection of FixQ was then possible with the nitrocellulose membrane. Visible light spectroscopy of purified enzymes was performed as described by Zufferey et al. (17). Heme B extraction and the pyridine hemochrome assay were performed as described by Berry and Trumpower (36). The copper content of the Chelex 100-treated, purified cytochrome c oxidase was determined by Flame Atomic Absorption Spectrometry (Perkin-Elmer, model 5000).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Mutagenesis of Conserved Histidines in FixN-- All conserved histidines of B. japonicum FixN were changed by site-directed mutagenesis to a smaller neutral amino acid to minimize possible structural effects on the protein. His-131 had already been proposed to be the N-terminal low spin heme B ligand based on sequence homology and mutant phenotype (1). His-316, His-246, His-333, and His-418 were changed to valine, whereas His-227, His-280, His-330, His-331, His-410, His-418, His-420, and His-457 were substituted by alanine. All plasmids containing the respective mutations were cointegrated into the chromosome of the Delta fixNOQP mutant, strain Bj4503 (14, 17), as described under "Experimental Procedures."

Functional Consequences of the Histidine Replacements-- We first analyzed the effect of the histidine replacements on cytochrome c oxidase activity in vivo. We performed the TMPD oxidation test with whole cells that had been grown under anaerobic conditions, because this terminal oxidase is expressed under such conditions (8). In this assay, TMPD is used as the artificial electron donor. The cbb3-type oxidase contributes to at least 50-60% of the total cellular TMPD oxidase activity under such conditions because the Delta fixN deletion mutant Bj4526 showed about 40% residual activity as compared with the positive control strain Bj4504 (fixNOQP+, Table II). This relatively high residual activity is caused by alternative cytochrome c oxidases (37) or by enzymes of the denitrification pathway (38, 39). The H227A, H246V, H333V, and H457A mutants oxidized TMPD to a similar extent as the positive control strain Bj4504 (70-100%). By contrast, histidine replacements at positions 280, 316, 330, 331, 410, 418, and 420 led to inactive enzymes because they all showed less than 50% TMPD oxidase activity like the Delta fixN in-frame deletion strain Bj4526.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Phenotypes of the B. japonicum mutants

The cbb3-type terminal oxidase had been shown to be essential in supporting nitrogen fixation (Fix phenotype) in symbiosis with soybean (8). Therefore, we measured nitrogenase activity in root nodules infected with the histidine mutant strains (Table II). The following mutants H227A, H246V, H333V, and H457A fixed nitrogen to a similar extent as the positive control strain Bj4504 (87-135%). By contrast, mutations at positions 280, 316, 330, 331, 410, 418, and 420 led to ineffective symbiotic nitrogen fixation, like the Delta fixN in-frame deletion mutant Bj4526 (residual 10-18% nitrogenase activity). The in vivo data indicate that the conserved histidines characteristic of heme-copper oxidases are important residues for in vivo activities, and four of the non-canonical histidines are apparently not essential for function.

With the exception of mutant H457A, similar results were also obtained when the membranes of the histidine mutants were probed for their ability to oxidize reduced horse heart cytochrome c. Membrane fractions were isolated from anaerobically grown cells by differential centrifugation and solubilized in dodecyl maltoside. Like Bj4526, the mutants H280A, H316V, H330A, H331A, H410A, H418V, H420A, and H457A were defective in oxidation of reduced horse heart cytochrome c, as they displayed only 8-17% of the wild-type level (Table II). By contrast, the H227A, H246V, and H333V mutant enzymes showed only marginally reduced activities (70-98%) as compared with the positive control strain.

Presence of Subunits in the Oxidase-- We analyzed the mutant enzymes on the protein level to check whether the functionally defective mutant strains still contained cbb3-type oxidase subunits. For this purpose, we performed Western blot analyses with antibodies specific to FixN, FixO, FixP, and CycM. The latter antibody was used as an internal control to ascertain that comparable levels of protein had been loaded in each lane. Membrane fractions of anaerobically grown cells were isolated. As expected, the positive control strain, Bj4504, contained the FixN, FixO, and FixP proteins, whereas the negative control strain, Bj4526, had an assembly defect of the enzyme (17), lacking all three proteins (Fig. 2, lanes 2 and 1, respectively). The mutants H418V (lane 4), H331A (lane 7), H410A (lane 8), and H457A (lane 13) had strongly decreased amounts of cbb3-type oxidase subunits in their membranes as compared with the positive control strain Bj4504. By contrast, H420A (lane 3), H280A (lane 5), H330A (lane 6), H227A (lane 9), H246V (lane 10), H316V (lane 11), and H333V (lane 12) displayed wild-type amounts of FixN, FixO, and FixP proteins in their membranes. Consequently, alanine replacement at positions 420, 280, 330, and 227 and valine substitution at positions 316 and 333 in FixN did not affect the assembly of the cbb3-oxidase, whereas the H418V, H331A, H410A, and H457 mutations led to assembly defective or instable enzymes. Heme staining of the membrane-bound c-type cytochromes indicated that whenever FixO and FixP were present, they were synthesized as holoproteins (data not shown).


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 2.   Western blot analysis of membrane proteins isolated from anaerobically grown cells. Four similar blots were developed using immunoglobulins against FixN, FixO, FixP, and cytochrome CycM, as indicated on the right. Approximately 30 µg of membrane proteins were loaded in each lane. The following strains were tested: Bj4526 (Delta fixN, lane 1), Bj4504 (fixNOQP+ by complementation, lane 2), H420A (lane 3), H418V (lane 4), H280A (lane 5), H330A (lane 6), H331A (lane 7), H410A (lane 8), H227A (lane 9), H246V (lane 10), H316V (lane 11), H333V (lane 12), and H457A (lane 13). AB, antibodies.

Considering the activities of the mutants and the detection of their subunits in the membrane, lack of functional activities correlates with the decreased amounts of cbb3-type oxidase subunits present in the membrane for mutants H331A, H410A, and H418V. This was not the case for mutants H280A, H316V, H330A, and H420A, which are apparently assembled and stable in the membrane. Thus, these four enzymes were considered to be good candidates for purification and further analysis. Their functional defect might be explained by structural alterations that do not disturb the assembly process.

Purification and Characterization of the His6-tagged cbb3-type Oxidase-- To purify the cbb3-type oxidase, six histidines were fused to the C terminus of FixN by genetic means, and the respective DNA construct was integrated in the chromosome of the Delta fixNOQP mutant Bj4503 (see "Experimental Procedures"). Preliminary tests showed that such a complex is properly assembled in the membrane, because FixN, FixO, and FixP subunits were detected by Western blot analyses with the respective immunoglobulins (data not shown), and because the cytochrome c oxidase activity was hardly affected (Table II). Hence, the addition of six histidines at the C terminus of FixN does not appear to affect the biogenesis and the activity of the enzyme.

The His6-tagged cbb3-type oxidase was purified from the solubilized membrane fraction by a three-step protocol as described under "Experimental Procedures" (Table III). A 20-fold enrichment of specific cytochrome c oxidase activity and a recovery of 70% of total membrane activity were obtained (Table III). From 40 mg of membrane protein, 1.3 mg of purified cbb3-type oxidase was recovered, which represents approximately 3.3% of solubilized membrane proteins. Three major bands of apparent molecular masses of 47, 32, and 28 kDa were visible on a SDS-polyacrylamide gel (Fig. 3A, lanes 1-4). The 47-kDa band corresponded to the His6-tagged FixN subunit because it was recognized by anti-FixN serum (Fig. 3B). The 32- and 28-kDa bands are cytochromes c because they are heme-stainable (Fig. 3A, lane 5) and correspond to FixO and FixP, respectively, as shown by their cross-reaction with immunoglobulins against FixP and FixO (Western blot not shown). The intensity of FixP heme staining was consistently stronger than that of FixO. This might reflect the fact that FixP is a diheme cytochrome c whereas FixO is a monoheme cytochrome c (14, 17, 18). The small fixQ gene product was not seen on a Schägger and von Jagow gel stained with Coomassie Blue and could be only detected with an antibody specific to a FixQ peptide. To test the specificity of the immunoglobulins, membrane proteins of wild-type cbb3-type oxidase (Bj4504) and Bj4503 (Delta fixNOQP) were loaded on a Schägger gel as positive and negative controls, respectively. The membrane proteins were blotted onto a nitrocellulose membrane laid behind a polyvinylidene difluoride membrane as described under "Experimental Procedures." Only the nitrocellulose membrane was stained with immunoglobulins specific to the C terminus of FixQ. A 4-kDa band could be assigned to FixQ because it was detected in the purified cbb3-type oxidase and in the membrane fraction of strain Bj4504 (fixNOQP+) but was absent in the Bj4503 (Delta fixNOQP) mutant (Fig. 3C, lanes 1-3). Thus, FixQ had a slightly aberrant migration behavior during SDS-PAGE (apparent molecular mass of 4 kDa compared with the theoretical molecular mass of 6,031 Da), which is not uncommon for membrane proteins. Hence, the cbb3-type oxidase will be also referred to as a FixNOQP-oxidase because all of the structural gene products are present in the purified enzyme preparation.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Purification of the His6-tagged wild-type and mutant cbb3-type oxidases from B. japonicum
Protein determination was done with the bicinchoninic acid assay, and horse heart cytochrome c oxidase activity was measured at 30 °C as described under "Experimental Procedures."


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 3.   Purification of the cbb3-type oxidase. A, SDS-PAGE of fractions from the different purification steps. Proteins were visualized by Coomassie Blue staining (lanes 1-4) or by heme staining (lane 5). Proteins from solubilized membranes and from the active fractions of the Q-Sepharose chromatography (15 and 8 µg, respectively) were loaded in lanes 1 and 2, respectively. Lanes 3 and 4 contain 2-µg samples from the Ni2+ affinity chromatography and Sephadex G-25 gel filtration, respectively. B, Western blot with immunoglobulins against FixN with 0.5 µg of the purified fraction. C, Western blot (12% Schägger gel) with immunoglobulins against FixQ. One µg of the purified oxidase (lane 1) and 70 µg of membrane proteins of Bj4503 (Delta fixNOQP, lane 2) and Bj4504 (fixNOQP+, lane 3) were loaded. The apparent molecular masses (kDa) of the marker proteins are indicated on the left.

The dithionite-reduced minus air-oxidized visible light spectra of the His6-tagged purified oxidase showed features similar to the wild-type enzyme as follows: two peaks at 551 and 561 nm diagnostic of c- and b-type cytochromes, respectively (Fig. 4A). The ratio between heme C and B (peaks at 551 and 561 nm, respectively) was estimated to be 1.73 by using the respective molar extinction coefficients 19.1 and 22 mM-1 cm-1 (40), which corresponded to the value obtained by Preisig et al. (14). To determine the stoichiometry of heme B per enzyme molecule, heme B was extracted from the purified oxidase preparation and quantified by the method of Berry and Trumpower (36). A value of 1.1 heme B per molecule was obtained (Table IV). This relatively low value may be due to some loss of heme during extraction.


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 4.   Analysis of wild-type and mutant His6-tagged cbb3-type oxidases (0.1 mg/ml) by room temperature difference spectroscopy. A, dithionite reduced minus air-oxidized difference spectra between 500 and 600 nm. The 551- and 561-nm peaks are diagnostic of c-type cytochromes and b-type cytochromes, respectively. B, second derivatives of dithionite reduced minus air-oxidized spectra between 510 and 590 nm. The 551- and 561-nm troughs are diagnostic of c-type cytochromes and b-type cytochromes, respectively.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Phenotypes of the His6-tagged cbb3-type oxidase mutants from B. japonicum
Bj4621 was used as the standard (100%). Values are given in percent with or without standard deviation. At least two measurements were done with each of the mutant proteins. The horse heart cytochrome c oxidase activity and the copper and heme B contents were determined as described under "Experimental Procedures." 100% cytochrome c oxidase activity represents 11.6 µmol of cytochrome c × min-1 × mg-1; 100% copper and heme B contents correspond to 0.76 copper and 1.1 heme B per cbb3-type oxidase complex, respectively. The molecular masses for the cbb3-type oxidase and the thioredoxin-like protein CycYHis* (41) are 127,536 and 17,935 Da, respectively. ND, not determined.

Flame atomic absorption spectrometry was applied to measure the copper content of the purified cbb3-type oxidase. To keep the level of unspecifically bound copper as low as possible, the purified enzyme preparation was treated with small amounts of Chelex 100 for 30 min (see "Experimental Procedures"). This treatment did not affect the cytochrome c oxidase activity of the enzyme (data not shown). 5.99 µmol of copper per mg of protein was obtained. Considering a molecular mass of 127,536 Da for 1 mol of cbb3-type oxidase, a stoichiometry of 0.76 copper per molecule of enzyme was calculated (Table IV), which is in agreement with the prediction that the FixN subunit contains one CuB. To exclude a role of the His6-tag in binding copper, CycYHis*, a thioredoxin-like protein devoid of metal cofactors, C-terminally tagged with six histidines, was purified as described previously (41) and incubated with Chelex 100 like the other probes. The copper content of CycYHis* was measured, and a stoichiometry of 0.03 per molecule (mass = 17,935 Da) was obtained. This value corresponded to 3.75% that of the purified wild-type His6-tagged enzyme produced by Bj4621 (Table IV). From this result, we would like to exclude a role of the His6-tag in copper binding.

Biochemical Characterization of Four His6-tagged Histidine Mutant Enzymes-- The H280A, H330A, H316V, and H420A mutants were chosen for purification and further examination because they produced inactive enzymes that were apparently assembled stably in the membrane. For this purpose, six histidines were added by genetic means at the C terminus of FixN as for the wild-type enzyme to allow a faster and more efficient purification procedure. It was not reasonable to attempt purification of the following mutant enzymes H331A, H410A, H418V, and H457A because they were present in very small amounts in the membrane or even completely absent. Moreover, it is quite possible that they are not suitable for purification because of their instability.

The H280A, H330A, H316V, and H420A His6-tagged mutant enzymes (from strains Bj4623, Bj4622, Bj4624, and Bj4625, respectively) were purified by the same procedure as the His6-tagged wild-type enzyme (from strain Bj4621). All of these mutant enzymes displayed less than 10% cytochrome c oxidase activity in vitro with reduced horse heart cytochrome c as the electron donor as compared with the His6-tagged wild-type enzyme (Table IV). Visible light spectroscopy of dithionite-reduced minus air-oxidized forms of the purified enzymes from Bj4622, Bj4623, and Bj4624 revealed similar amounts of cytochromes b and c compared with the His6-tagged wild-type enzyme, because the 551- and 561-nm peaks were present in a comparable stoichiometry (Fig. 4A). By contrast, the Bj4625 mutant apparently lacked the reducible heme B moiety because the specific peak at 561 nm was missing in the dithionite-reduced minus air-oxidized spectrum, which was even more obvious in its second derivative (Fig. 4B). To check whether the enzyme from the Bj4625 mutant still contained heme B or not, the non-covalently bound heme B was extracted and quantified by pyridine hemochrome spectroscopy according to Berry and Trumpower (36). The Bj4625 enzyme contained a similar amount (90%) of heme B compared with the wild-type His6-tagged enzyme of Bj4621 (Table IV), indicating that its heme B moiety is present but probably cannot be reduced.

The copper content was measured by flame atomic absorption spectrometry, using purified enzyme preparations that had been treated with Chelex 100 as the wild-type enzyme. All mutants, Bj4622, Bj4623, Bj4624, and Bj4625, contained enzymes with similar stoichiometric amounts of copper as the His6-tagged wild-type enzyme from Bj4621 (Table IV).

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

In this work, we expand on the biochemical characterization of the B. japonicum cbb3-type oxidase and present a systematic mutational analysis of the 12 conserved histidines in its subunit I (FixN protein).

The B. japonicum cbb3-type oxidase is encoded by the fixNOQP operon. In a previous study we have shown that the structural genes fixN, fixO, and fixP, coding for subunits I, II and III, respectively, are essential for the formation of a functional oxidase complex. By contrast, fixQ could be eliminated without loss of oxidase activity and assembly of the FixN, FixO, and FixP proteins in the membrane. Nevertheless, it was striking to learn that all known bacterial operons encoding a cbb3-type oxidase contained a fixQ-like gene (8-13, 42),2 suggesting that its product is a real but non-essential subunit of the oxidase. Until recently, we had been unable to detect a protein of approximately 6 kDa corresponding to the predicted molecular mass of FixQ in our oxidase preparations (14).

In this work an improved procedure for purification of the cbb3-type oxidase was established, which makes use of a C-terminal His6-tag fused to the FixN polypeptide. This not only allowed a more rapid and reproducible purification procedure, including a Ni2+ affinity chromatography, but also made possible the purification of inactive cbb3-type oxidases as His6-tagged derivatives. The preparation of the His6-tagged wild-type enzyme led to unaltered cytochrome c oxidase activity and contained the same b- and c-type cytochromes as described for the wild-type oxidase by Preisig et al. (14). Three major protein bands were detected by SDS-PAGE and recognized as the FixN, FixO, and FixP proteins by Western blot analysis. With the help of a FixQ peptide-specific antiserum it was possible for the first time to detect the fourth small subunit, FixQ, in a cbb3-type oxidase. Thus, FixQ is a true constituent of the cbb3-type oxidase, even though it is neither essential for the function nor for the assembly of the enzyme (17). The presence of a small subunit with no detectable function in an oxidase complex is also known from the P. denitrificans aa3-type cytochrome c oxidase; the oxidase crystals clearly contain subunit IV (3), which is the product of a gene (ctaH) that can be deleted without affecting oxidase assembly or function (43).

Owing to the new purification protocol reported here, it was possible to obtain a 2-3-fold higher yield of the cbb3-type oxidase with apparently fewer contaminating proteins. This allowed us to measure the contents of heme and copper in the enzyme. A relatively low value of 1.1 heme B molecule per oxidase complex was obtained, which might be due to some loss of heme during extraction. With respect to copper, a stoichiometry of 0.76 atoms per enzyme complex was calculated, supporting the previous assumption that the B. japonicum cbb3-type oxidase contains one copper per enzyme complex. This copper atom is most likely part of the heme B-CuB binuclear center present in subunit I, because a classical subunit II with a binuclear CuA center is missing in the cbb3-type subclass of cytochrome c oxidases (8, 15, 16).

Subunit I of the cbb3-type oxidases contains 12 conserved histidine residues, of which 6 can be predicted to serve as the cofactor ligands based on sequence similarities with the P. denitrificans aa3-type oxidase whose structure is known (3). We created a complete set of fixN mutants by changing each of the conserved histidines to a smaller, neutral amino acid to test the importance of these residues in oxidase assembly and function.

All six histidines with predicted cofactor liganding functions turned out to be essential for cbb3-type oxidase activity. We had shown previously that His-131 was essential for assembly of the oxidase subunits (18). This histidine resides on the periplasmic side of the second transmembrane helix of FixN (Fig. 1) and therefore serves most probably as a low spin heme ligand. However, since the H131A mutant oxidase is unstable, a role of this histidine in binding heme B could not be assessed directly.

Based on the amino acid sequence similarity between subunits I of heme copper oxidases, the second presumed low spin heme ligand is His-420. The H420A mutant contained a fully assembled but inactive cbb3-type oxidase. The corresponding purified His6-tagged mutant protein contained normal amounts of heme B and copper, suggesting that His-420 is not required for incorporation of the cofactors. However, the reduced minus oxidized difference spectrum lacked the peak at 561 nm that is indicative for reducible heme B. A similar phenotype was found in the equivalent bo3-type oxidase mutant of E. coli (44). We propose that His-420 is the second low spin heme ligand and is required for correctly positioning heme in the assembled oxidase so that electron flow can take place.

His-418 was predicted to be the high spin heme ligand. Mutation of this residue led to an assembly defect of the oxidase and, by consequence, to lack of enzymatic activity. Therefore, the role of His-418 as a cofactor ligand could not be investigated further.

The putative CuB ligands His-280, His-330, and His-331 were changed to alanines, which resulted in inactive oxidases. It thus appeared as if all three ligands are necessary to hold CuB in a reactive binuclear center to permit full oxidase activity. Although the H331A mutant oxidase had a defect in assembly, the H280A and H330A mutant oxidases could be purified as His6-tagged variants and showed normal amounts of heme B and copper cofactors. This result does not contradict the assumption that these residues are CuB ligands. If either His-280 or His-330 is altered, the other two putative ligands (His-330 plus His-331 or His-280 plus His-331, respectively) might be sufficient to bind copper to the oxidase during the assembly process. To ascertain the role of these two histidines in complexing CuB, further refined spectroscopic analyses and the construction of various double mutants would be required.

Three of the six histidines that are conserved in cbb3-type oxidases, but not in other classical heme copper oxidases, can be altered without any effect on oxidase formation or activity as follows: His-227 and His-246 on either side of transmembrane helix V and His-333 on the periplasmic side of transmembrane helix VII (Fig. 1).

The mutant H457A, in which the conserved histidine on the cytoplasmic side of transmembrane helix XI was altered, displayed wild-type levels of TMPD oxidase and nitrogenase activities in vivo. However, a slight defect in cytochrome c oxidase activity was observed in isolated membranes that also contained diminished amounts of cbb3 oxidase subunits. This suggests that the H457A exchange per se, rather than affecting the formation and activity of the oxidase, renders the FixN protein more fragile during cell fractionation and, therefore, causes some loss of the complex in membrane preparations.

His-410 resides in a periplasmic domain between the transmembrane helices IX and X and appears to be required for the formation of a stable oxidase, because the H410A mutant enzyme does not assemble in the membrane. In the P. denitrificans aa3-type oxidase a histidine (His-403) in the corresponding periplasmic loop has been proposed to be part of a binding site for a redox-inactive Mg2+ or Mn2+ center (6, 7), and mutation of the corresponding His-411 in the Rhodobacter sphaeroides aa3-type oxidase led to lower activity and loss of Mn2+ binding (21). Therefore, it is possible that the cbb3-type oxidase also possesses such an additional metal center involving His-410 and that the metal contributes to assembly of the subunits.

Beyond the essential histidines discussed so far, whose function could be backed up by comparison with the cytochrome aa3 structure, His-316 was the sole FixN-specific, conserved histidine found to be essential for oxidase function. CuB content and visible spectroscopic features of the His6-tagged H316V mutant oxidase resembled those of the corresponding His6-tagged wild-type enzyme. This histidine is predicted to be localized on the cytoplasmic side of the membrane of transmembrane helix V (Fig. 1) and might be a candidate for binding and releasing protons. Two processes involving proton translocation can be expected for the cbb3-type oxidase: (i) scalar proton translocation to the binuclear center for H2O formation, and (ii) vectorial proton pumping across the membrane to establish an electrochemical proton gradient, a process demonstrated for the P. denitrificans cbb3-type oxidase (13). Since several amino acids that have been proposed to be involved in these translocation processes in the aa3-type oxidase are not conserved in the cbb3-type oxidase, the mechanisms how protons move inside and through the latter enzyme are completely unknown. Moreover, proton translocation has not been demonstrated yet for the B. japonicum FixNOQP oxidase. At present it is therefore too early to assign a role in proton translocation to His-316. Since the H316V mutant enzyme is not affected in membrane insertion, stability, and cofactor binding, it might serve as a valuable tool to analyze the coupling of proton translocation and electron transfer reactions in this type of oxidase.

By and large, the replacement of putative cofactor ligands by other amino acids provided valuable insight into the assembly process of the cbb3-type oxidase. Assembled but inactive histidine mutant proteins lacking the heme B or CuB moieties have never been found. This strongly suggests that low spin and high spin heme B as well as CuB incorporations are essential for the assembly and stability of the B. japonicum cbb3-type oxidase, and these processes seem to represent an early step in the biogenesis of the enzyme. At this stage of the analysis, it is not possible to predict whether heme B and copper insertions occur as sequential processes.

The results presented in this paper are fully consistent with the assumption that those six invariant histidines of the cbb3-type oxidase that are common to all heme-copper oxidases are involved in cofactor binding in a similar way as it is known for the aa3-type oxidase. Also, a similar organization of the transmembrane helices around the heme B and CuB cofactors can be postulated. Our mutational analysis of subunit I (FixN) reinforces the idea that the cbb3-type oxidases share structural similarities with the classical heme-copper oxidases. By contrast, the role of the additional six histidines and the reason why they were conserved during evolution of almost all of the cbb3-type oxidases remain obscure. Notably, after this manuscript was completed, we learned from the complete nucleotide sequence of the Helicobacter pylori genome that the sole cytochrome oxidase this bacterium has is of the cbb3-type and that its subunit I lacks five of the FixN-specific conserved histidines (corresponding to His-227, His-246, His-316, His-333, and His-457 of B. japonicum FixN; see Ref. 42, GenBank accession number AE000536). It is remarkable and fully consistent with our data that among the seven remaining histidines of the H. pylori subunit I are the six canonical ones and the one that has been implicated in Mg2+ or Mn2+ binding (see above).

For future studies with the B. japonicum cbb3-type oxidase, we are in need of larger quantities of the enzyme. The His6-tagged subunit I, as shown in this work, has aided in the purification, and we hope that this tool will be useful in scaling up the purification procedure.

    ACKNOWLEDGEMENT

We thank Dr. Nenad Blau (Department of Pediatrics, University of Zürich) for performing the copper determination.

    FOOTNOTES

* This work was supported by a grant from the Swiss National Foundation for Scientific Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 41-1-632-3318; Fax: 41-1-632-1382; E-mail: hennecke{at}micro.biol.ethz.ch.

1 The abbreviations used are: PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; TMPD, N,N,N',N'-tetramethyl-p-phenylenediamine; kb, kilobase pairs.

2 J. A. García-Horsman, M. Toledo-Cuevas, B. Barquera, R. B. Gennis, and M. Wikström, GenBank accession number U58092.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Zufferey, R., Thöny-Meyer, L., and Hennecke, H. (1996) FEBS Lett. 394, 349-352[CrossRef][Medline] [Order article via Infotrieve]
  2. García-Horsman, J. A., Barquera, B., Rumbley, J., Ma, J., and Gennis, R. B. (1994) J. Bacteriol. 176, 5587-5600[Medline] [Order article via Infotrieve]
  3. Iwata, S., Ostermeier, C., Ludwig, B., and Michel, H. (1995) Nature 376, 660-669[CrossRef][Medline] [Order article via Infotrieve]
  4. Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., and Yoshikawa, S. (1995) Science 269, 1069-1074[Medline] [Order article via Infotrieve]
  5. Tsukihara, T., Aoyama, H., Yamashita, E., Tomizaki, T., Yamaguchi, H., Shinzawa-Itoh, K., Nakashima, R., Yaono, R., and Yoshikawa, S. (1996) Science 272, 1136-1144[Abstract]
  6. Lauraeus, M., Haltia, T., Saraste, M., and Wikström, M. (1991) Eur. J. Biochem. 197, 699-706[Abstract]
  7. Puustinen, A., Finel, M., Haltia, T., Gennis, R. B., Wikström, M. (1991) Biochemistry 30, 3936-3942[Medline] [Order article via Infotrieve]
  8. Preisig, O., Anthamatten, D., and Hennecke, H. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3309-3313[Abstract]
  9. Kahn, D., Batut, J., Daveran, M.-L., and Fourment, J. (1993) in New Horizons in Nitrogen Fixation (Palacios, R., Mora, J., and Newton, W. E., eds), p. 474, Kluwer Academic Publishers Group, Drodrecht, Netherlands
  10. Mandon, K., Kaminsky, P. A., and Elmerich, C. (1994) J. Bacteriol. 174, 6444-6454[Abstract]
  11. Schlüter, A., Patschkowski, T., Quandt, J., Selinger, L. B., Weidner, S., Krämer, M., Zhou, L., Hynes, M. F., Priefer, U. (1997) Mol. Plant-Microbe Interact. 10, 605-616[Medline] [Order article via Infotrieve]
  12. Thöny-Meyer, L., Beck, C., Preisig, O., and Hennecke, H. (1994) Mol. Microbiol. 174, 705-716
  13. de Gier, J.-W. L., Schepper, M., Rejinders, W. N. M., van Dyck, S. J., Slotboom, D. J., Warne, A., Saraste, M., Krab, K., Finel, M., Stouthamer, A. H., van Spanning, R. J. M., van der Oost, J. (1996) Mol. Microbiol. 20, 1247-1260[Medline] [Order article via Infotrieve]
  14. Preisig, O., Zufferey, R., Thöny-Meyer, L., Appleby, C. A., Hennecke, H. (1996) J. Bacteriol. 178, 1532-1538[Abstract]
  15. García-Horsman, J. A., Berry, E., Shapleigh, J. P., Alben, J. O., Gennis, R. B. (1994) Biochemistry 33, 3113-3120[Medline] [Order article via Infotrieve]
  16. Gray, K. A., Grooms, M., Myllykallio, H., Moomaw, C., Slaughter, C., and Daldal, F. (1994) Biochemistry 33, 3120-3127[Medline] [Order article via Infotrieve]
  17. Zufferey, R., Preisig, O., Hennecke, H., and Thöny-Meyer, L. (1996) J. Biol. Chem. 271, 9114-9119[Abstract/Free Full Text]
  18. Zufferey, R., Hennecke, H., and Thöny-Meyer, L. (1997) FEBS Lett. 412, 75-78[CrossRef][Medline] [Order article via Infotrieve]
  19. Tamegai, H., and Fukumori, Y. (1994) FEBS Lett. 347, 22-26[CrossRef][Medline] [Order article via Infotrieve]
  20. Hosler, J. P., Ferguson-Miller, S., Calhoun, M. W., Thomas, J. W., Hill, J., Lemieux, L., Ma, J., Georgiou, C., Fetter, J., Shapleigh, J., Tecklenburg, M. M. J., Babcock, G. T., Gennis, R. B. (1993) J. Bioenerg. Biomembr. 25, 121-136[CrossRef][Medline] [Order article via Infotrieve]
  21. Hosler, J. P., Espe, M. P., Zhen, Y., Babcock, G. T., Ferguson-Miller, S. (1995) Biochemistry 34, 7586-7592[Medline] [Order article via Infotrieve]
  22. Espe, M. P., Hosler, J. P., Ferguson-Miller, S., Babcock, G. T., McCracken, J. (1995) Biochemistry 34, 7593-7602[Medline] [Order article via Infotrieve]
  23. Regensburger, B., and Hennecke, H. (1983) Arch. Microbiol. 135, 103-109[Medline] [Order article via Infotrieve]
  24. Daniel, R. M., and Appleby, C. A. (1972) Biochim. Biophys. Acta 275, 347-354[Medline] [Order article via Infotrieve]
  25. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  26. Hanahan, D. (1983) J. Mol. Biol. 166, 557-580[Medline] [Order article via Infotrieve]
  27. Messing, J. (1983) Methods Enzymol. 101, 20-78[Medline] [Order article via Infotrieve]
  28. Simon, R., Priefer, U., and Pühler, A. (1983) in Molecular Genetics of the Bacteria-Plant Interaction (Pühler, A., ed), pp. 98-106, Springer-Verlag, Heidelberg
  29. Hahn, M., and Hennecke, H. (1984) Mol. Gen. Genet. 193, 46-52
  30. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467[Abstract]
  31. Landt, O., Grunert, H.-P., and Hahn, U. (1990) Gene (Amst.) 96, 125-128[CrossRef][Medline] [Order article via Infotrieve]
  32. Sayers, J., and Eckstein, F. (1991) in Directed Mutagenesis: A Practical Approach (McPherson, M. J., ed), pp. 49-70, Oxford University Press, Oxford
  33. Laemmli, U. K. (1970) Nature 227, 680-685[Medline] [Order article via Infotrieve]
  34. Schägger, H., and von Jagow, G. (1987) Anal. Biochem. 166, 368-379[Medline] [Order article via Infotrieve]
  35. Preisig, O., Zufferey, R., and Hennecke, H. (1996) Arch. Microbiol. 165, 297-305[CrossRef][Medline] [Order article via Infotrieve]
  36. Berry, E. A., and Trumpower, B. L. (1987) Anal. Biochem. 161, 1-15[Medline] [Order article via Infotrieve]
  37. Bott, M., Preisig, O., and Hennecke, H. (1992) Arch. Microbiol. 158, 335-343[Medline] [Order article via Infotrieve]
  38. Yamazaki, T., Oyanagi, H., Fujiwara, T., and Fukumori, Y. (1995) Eur. J. Biochem. 233, 665-671[Abstract]
  39. Fujiwara, T., and Fukumori, Y. (1996) J. Bacteriol. 178, 1866-1871[Abstract]
  40. Jones, C. W., and Poole, R. K. (1985) Methods Microbiol. 18, 285-328
  41. Fabianek, R. A., Huber-Wunderlich, M., Glockshuber, R., Künzler, P., Hennecke, H., and Thöny-Meyer, L. (1997) J. Biol. Chem. 272, 4467-4473[Abstract/Free Full Text]
  42. Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., Nelson, K., Quackenbush, J., Zhou, L., Kirkness, E. F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H. G., Glodek, A., McKenney, K., Fitzegerald, L. M., Lee, N., Adams, M. D., Hickey, E. K., Berg, D. E., Gocayne, J. D., Utterback, T. R., Peterson, J. D., Kelley, J. M., Cotton, M. D., Weidman, J. M., Fujii, C., Bowman, C., Watthey, L., Wallin, E., Hayes, W. S., Borodovsky, M., Karp, P. D., Smith, H. O., Fraser, C. M., Venter, J. C. (1997) Nature 388, 539-547[CrossRef][Medline] [Order article via Infotrieve]
  43. Witt, H., and Ludwig, B. (1997) J. Biol. Chem. 272, 5514-5517[Abstract/Free Full Text]
  44. Lemieux, L. J., Calhoun, M. W., Thomas, J. W., Ingledew, J. W., Gennis, R. B. (1992) J. Biol. Chem. 267, 2105-2113[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.